AADX enters the final week of September with a striking and sudden shift in short positioning — one of the sharpest weekly build-ups the stock has seen since its NYSE debut.
The headline number is hard to ignore: short interest has tripled over the past week, rising 201% to roughly 8.7 million shares. Over the past month the build is even more dramatic — up 566% from a base of around 1.1 million shares in mid-August. That kind of acceleration in a relatively short time is unusual, and it has moved the ORTEX short score sharply higher, from 42 two weeks ago to 72.5 now — close to the top quartile of the universe. The borrow market reflects the same pressure. Availability has collapsed from above 400% earlier this month to just 110% today, meaning there is now roughly one share available for every one already borrowed — down from more than four shares available per borrowed share just ten days ago. The tightening is among the steepest in the 30-day window, and the direction is still falling. Yet cost-to-borrow remains low at 0.82% — actually down nearly 20% on the week — which suggests the lending pool is tightening in volume terms but has not yet repriced to reflect that scarcity. That divergence is worth watching: if availability continues to compress while borrow cost stays subdued, a repricing of the borrow rate may follow.
Options traders are reading the situation differently from short sellers. The put/call ratio has fallen to 0.44, almost 1.3 standard deviations below its 20-day average of 0.60 — a notably call-heavy skew. A month ago the PCR was running above 0.80, meaning options positioning has rotated sharply toward calls even as short interest surged. The 52-week PCR low is 0.0, so the current reading is not extreme on an absolute basis, but the direction of travel — heavy call interest alongside a rapid short build — creates an unusual tension in the positioning picture. Bulls in options appear to be betting on a recovery from the stock's 12% one-month decline to $12.64, while short sellers are adding exposure at the same time.
The Street sits firmly in the bull camp on valuation. The consensus is Buy, with a mean price target of $25.75 — more than double the current price. Guggenheim initiated coverage earlier this month with a Buy rating and a $30 target, the most aggressive on the board. B of A Securities and Morgan Stanley both kept their ratings intact after the August earnings print, though BofA trimmed its target modestly to $23. The bull case centres on mid-teens organic growth potential, a strengthened balance sheet following the Consolidated Boring acquisition, and exposure to high-technology defense platforms. Bears point to customer concentration, fixed-price contract risk, sole-source supplier bottlenecks, and the fact that the sponsor — AA&D Holdings — still controls 73.5% of shares outstanding, creating a persistent overhang and controlled-company governance dynamics. The EV/EBITDA multiple of 16.3x has drifted slightly lower over the past 30 days, consistent with the stock's underperformance, while the price-to-book has eased to 2.3x.
The ownership picture is dominated by that sponsor stake. AA&D Holdings filed a Schedule 13G in August — a passive disclosure — holding 126.8 million shares, or 73.5% of the company. That structure limits the freely tradeable float considerably, which helps explain how short interest as a raw share count can triple in a week without the percentage-of-float figure appearing extreme in absolute terms: the denominator is already compressed. Among external institutional holders, AllianceBernstein, Temasek, MFS, and Baron Capital all appear as new positions in the most recent filings, suggesting that early institutional interest has been building since the IPO. Insider activity from June showed a cluster of open-market purchases at $20 by the CFO, a director, and two other board members — all discretionary, none under a 10b5-1 plan — totalling around $1.17 million in net buying at a price well above today's $12.64.
The next earnings event is scheduled for November 12. The only historical print on record produced a one-day move of -8.7% and a five-day move of -16%, so the stock has already demonstrated it can sell off sharply on results. With short interest now running at its highest level since listing, availability tightening daily, and the stock already down 12% in a month, the November print will be closely watched for any sign of whether the recent short accumulation reflects genuine fundamental concern or simply a positioning reset after a post-IPO overhang unwind.
See the live data behind this article on ORTEX.
Open AADX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
